Cis-disamminedichloroplatinum (II) CDDP: single agent in the treatment of advanced head and neck squamous cell carcinoma.
Seventeen patients with head and neck squamous cell carcinoma were treated with cis-diamminedichloroplatinum (II) CDDP 2.5 mg./kg. I.V. as a single agent. One complete and five partial responses were observed with only moderate toxicity.